6176 Federal Register / Vol. 87, No. 23 / Thursday, February 3, 2022 / Notices 

CMS–10036—IRF–PAI for the 

Collection of Data Pertaining to the 

Inpatient Rehabilitation Facility 

Prospective Payment System and 

Quality Reporting Program 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: IRF–PAI for the 

Collection of Data Pertaining to the 

Inpatient Rehabilitation Facility 

Prospective Payment System and 

Quality Reporting Program; Use: We are 

requesting an extension of the Inpatient 

Rehabilitation Facility-Patient 

Assessment Instrument (IRF–PAI) 

Version 4.0 that will be effective on 

October 1, 2022. On November 2, 2021, 

we issued a final rule (86 FR 62240) 

which finalized proposed modifications 

to the effective date for the reporting of 

measures and certain standardized 

patient assessment data in the Inpatient 

Rehabilitation Facility Quality 

Reporting Program (IRF QRP). Per the 

final rule CMS will require IRFs to start 

collecting assessment data using IRF– 

PAI Version 4.0 beginning October 1, 

2022. 

The information collection request for 

IRF PAI 4.0 was re-approved on 

December 15, 2021 with an October 1, 

2022 implementation date. CMS is 

asking for an extension of the approved 

IRF–PAI Version 4.0, which expires on 

December 31, 2022. The burden 

associated with this requirement is staff 

time required to complete and encode 

the data from the IRF–PAI. The burden 

associated with collecting and 

transmitting the data is unaffected by 

the proposed extension to the 

assessment instrument. 

The IRF–PAI is required by the CMS 

as part of the Inpatient Rehabilitation 

Facility Prospective Payment System 

(IRF PPS). CMS uses the data to 

determine the payment for each 

Medicare Part A fee-for-service patient 

and Medicare Part C (Medicare 

Advantage) admitted to an inpatient 

rehabilitation unit or hospital. The IRF– 

PAI is also used to gather data for the 

IRF Quality Reporting Program (IRF 

QRP). Form Number: CMS–10036 (OMB 

control number: 0938–0842); Frequency: 

Annually; Affected Public: Private 

Sector: Business and for-profit and Notfor-profit, State, Local or Tribal 

Government and Federal Government; 

Number of Respondents: 1,122; Total 

Annual Responses: 411,622; Total 

Annual Hours: 704,747. For policy 

questions regarding this collection, 

contact Ariel Adams at 410–786–8571.) 

Dated: January 28, 2022. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2022–02185 Filed 2–2–22; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; ACF 

Uniform Project Description (UPD) 

AGENCY: Office of Administration, Office 

of Grants Policy, Administration for 

Children and Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Administration for 

Children and Families (ACF) is 

requesting a 3-year extension of the ACF 

Uniform Project Description (UPD) 

(OMB #0970–0139, expiration 2/28/ 

2022). There are no changes requested 

to the form. ACF expects to submit a 

request for revisions in 2022, which will 

include standard comment periods. 

DATES: Comments due within 30 days of 

publication. OMB must make a decision 

about the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. You can also request 

copies of the proposed collection of 

information by emailing infocollection@

acf.hhs.gov. Identify all requests by the 

title of the information collection. 

SUPPLEMENTARY INFORMATION: 

Description: The proposed 

information collection would renew the 

ACF UPD. The UPD provides a uniform 

format for applicants to submit project 

information in response to ACF 

discretionary Notices of Funding 

Opportunities. The UPD requires 

applicants to describe how program 

objectives will be achieved and provide 

a rationale for the project’s budgeted 

costs. All ACF discretionary grant 

programs are required to use the UPD. 

ACF uses this information, along with 

other OMB-approved information 

collections (Standard Forms), to 

evaluate and rank applications. Use of 

the UPD protects the integrity of the 

ACF award selection process. 

Respondents: Applicants responding 

to ACF Discretionary Notices of 

Funding Opportunities. 

ANNUAL BURDEN ESTIMATES

Instrument 

Total 

number of 

respondents 

Annual 

number of 

responses per 

respondent 

Average 

burden hours 

per response 

Annual 

burden hours 

ACF Uniform Project Description ..................................................................... 4,170 1 60 250,200 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 23 / Thursday, February 3, 2022 / Notices 6177 

Estimated Total Annual Burden 

Hours: 250,200. 

Authority: 45 CFR 75.203–75.204 and 

45 CFR part 75, Appendix I. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–02177 Filed 2–2–22; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meetings of the Presidential Advisory 

Council on Combating AntibioticResistant Bacteria 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that a meeting is scheduled to be held 

for the Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB). The meeting will be open 

to the public via Zoom and 

teleconference; a pre-registered public 

comment session will be held during 

the meeting. Pre-registration is required 

for members of the public who wish to 

present their comments at the meeting 

via Zoom/teleconference. Individuals 

who wish to send in their written public 

comment should send an email to 

CARB@hhs.gov. Registration 

information is available on the website 

http://www.hhs.gov/paccarb and must 

be completed by February 25, 2022 for 

the March 2, 2022 Public Meeting. 

Additional information about registering 

for the meeting and providing public 

comment can be obtained at http://

www.hhs.gov/paccarb on the Upcoming 

Meetings page. 

DATES: The meeting is scheduled to be 

held on March 2, 2022, from 10:00 a.m. 

to 4:00 p.m. ET (times are tentative and 

subject to change). The confirmed times 

and agenda items for the meeting will be 

posted on the website for the PACCARB 

at http://www.hhs.gov/paccarb when 

this information becomes available. Preregistration for attending the meeting is 

strongly suggested and should be 

completed no later than February 25, 

2022. 

ADDRESSES: Instructions regarding 

attending this meeting virtually will be 

posted at least one week prior to the 

meeting at: http://www.hhs.gov/ 

paccarb. 

FOR FURTHER INFORMATION CONTACT: 

Jomana Musmar, M.S., Ph.D., 

Designated Federal Officer, Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria, Office of 

the Assistant Secretary for Health, U.S. 

Department of Health and Human 

Services, Room L616, Switzer Building, 

330 C St. SW, Washington, DC 20024. 

Phone: 202–746–1512; Email: CARB@

hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB), established by Executive 

Order 13676, is continued by Section 

505 of Public Law 116–22, the 

Pandemic and All-Hazards 

Preparedness and Advancing Innovation 

Act of 2019 (PAHPAIA). Activities and 

duties of the Advisory Council are 

governed by the provisions of the 

Federal Advisory Committee Act 

(FACA), Public Law 92–463, as 

amended (5 U.S.C. App.), which sets 

forth standards for the formation and 

use of federal advisory committees. 

The PACCARB shall advise and 

provide information and 

recommendations to the Secretary 

regarding programs and policies 

intended to reduce or combat antibioticresistant bacteria that may present a 

public health threat and improve 

capabilities to prevent, diagnose, 

mitigate, or treat such resistance. The 

PACCARB shall function solely for 

advisory purposes. 

Such advice, information, and 

recommendations may be related to 

improving: The effectiveness of 

antibiotics; research and advanced 

research on, and the development of, 

improved and innovative methods for 

combating or reducing antibiotic 

resistance, including new treatments, 

rapid point-of-care diagnostics, 

alternatives to antibiotics, including 

alternatives to animal antibiotics, and 

antimicrobial stewardship activities; 

surveillance of antibiotic-resistant 

bacterial infections, including publicly 

available and up-to-date information on 

resistance to antibiotics; education for 

health care providers and the public 

with respect to up-to-date information 

on antibiotic resistance and ways to 

reduce or combat such resistance to 

antibiotics related to humans and 

animals; methods to prevent or reduce 

the transmission of antibiotic-resistant 

bacterial infections; including 

stewardship programs; and coordination 

with respect to international efforts in 

order to inform and advance the United 

States capabilities to combat antibiotic 

resistance. 

The March 2, 2022, public meeting 

will be dedicated to providing a One 

Health retrospective on past novel viral 

outbreaks and how they impacted 

antimicrobial use, resistance, and 

stewardship. The meeting agenda will 

be posted on the PACCARB website at 

http://www.hhs.gov/paccarb when it has 

been finalized. All agenda items are 

tentative and subject to change. 

Instructions regarding attending the 

meeting virtually will be posted at least 

one week prior to the meeting at: http:// 

www.hhs.gov/paccarb. 

Members of the public will have the 

opportunity to provide comments live 

during the March meeting by preregistering online at http://

www.hhs.gov/paccarb. Pre-registration 

is required for participation in this 

session with limited spots available. 

Written public comments can also be 

emailed to CARB@hhs.gov by midnight 

February 25, 2022, and should be 

limited to no more than one page. All 

public comments received prior to 

February 25, 2022, will be provided to 

the Advisory Council members. 

Additionally, companies and/or 

organizations involved in combating 

antibiotic resistance have an 

opportunity to present their work to 

members of the Advisory Council live 

during an Innovation Spotlight. Preregistration is required for participation, 

with limited spots available. All 

information regarding this session can 

also be found online at http://

www.hhs.gov/paccarb. 

Dated: January 27, 2022. 

Jomana F. Musmar, 

Designated Federal Officer, Presidential 

Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant 

Secretary for Health. 

[FR Doc. 2022–02291 Filed 2–2–22; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Arthritis, Connective 

Tissue and Skin Study Section, 

February 17–18, 2022, 9:00 a.m. to 7:00 

p.m., which was published in the 

Federal Register on January 19, 2022, 

FR DOC 2022–00962, 87 FR 2878. 

This notice is being amended to 

change the meeting date from February 

17–18, 2022, 9:00 a.m. to 7:00 p.m. to 

February 16–18, 2022, 12:00 p.m. to 

7:00 p.m. The meeting place remains the 


khammond on DSKJM1Z7X2PROD with NOTICES